{"chebi_id":"5292","chebi_name":"geldanamycin","chebi_synonyms":["GELDANAMYCIN","(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate","Geldanamycin"],"diffprof_id_observed":["MTBLS2825_0001_00000004","MTBLS2871_0001_00000009","MTBLS3750_0001_00000006","MTBLS4893_0003_00000003","MTBLS5195_0002_00000001"],"diffprof_id_var_observed":["MTBLS2825_0001_00000004","MTBLS2871_0001_00000009","MTBLS3750_0001_00000006","MTBLS4893_0003_00000003"],"inchikey":"QTQAWLPCGQOSGP-KSRBKZBZSA-N","inn_name":"","iupac_name":"(4<i>E</i>,6<i>Z</i>,8<i>S</i>,9<i>S</i>,10<i>E</i>,12<i>S</i>,13<i>R</i>,14<i>S</i>,16<i>R</i>)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate","num_study_observed":5,"reactome_ids":["R-HSA-1236382","R-HSA-1643685","R-HSA-1643713","R-HSA-5637810","R-HSA-5637812","R-HSA-5637815","R-HSA-5663202"],"reactome_names":["Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","Disease","Signaling by EGFR in Cancer","Constitutive Signaling by EGFRvIII","Signaling by EGFRvIII in Cancer","Signaling by Ligand-Responsive EGFR Variants in Cancer","Diseases of signal transduction by growth factor receptors and second messengers"],"study_id_observed":["MTBLS2825","MTBLS2871","MTBLS3750","MTBLS4893","MTBLS5195"],"study_id_var_observed":["MTBLS2825","MTBLS2871","MTBLS3750","MTBLS4893"],"synonym_name":"GELDANAMYCIN"}